View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Following last month's news that Hill's had pulled out of BSAVA and would instead be found at a pizza restaurant round the corner from the NIA, comes a fresh announcement that the company has changed venues, and will now be at the Slug and Lettuce for the duration of Congress.
What next? I'm half expecting another press release before Congress kicks off, inviting us all to meet at John's.
The meeting, which is sponsored by Swann Morton, is the first in a series called ‘Let’s Talk About …’, where the idea is to get a small, representative group of eight general practitioners from around the country to come and put questions about a variety of different subjects to experts in their field, with the answers then being shared on YouTube for the benefit of colleagues not just in this country but around the world.
To apply to be one of the eight ‘questioners’ in ‘Let’s Talk About Small Animal Surgery', please email editor@vetsurgeon.org with your name, county and a question.
If you'd like to just watch the event, you can register here now.
Note that there may (or may not) be an opportunity for spectators to ask questions on the night. So if you want a VIP seat at the table, email your question as soon as possible.
For more information about Swann Morton, and its diverse range of Sheffield-made products incorporating the latest sharps safety solutions to protect the welfare of your in-house team, visit: www.swann-morton.com
UPDATE: THE RECORDING OF THIS MEETING IS NOW FREELY AVAILABLE FOR EVERYONE TO WATCH HERE, AND COUNTS TOWARDS YOUR CPD REQUIREMENT.
The research also found that awareness of feline hypertension amongst cat owners is very low, with 80% of those questioned unaware that cats could have high blood pressure and nearly 20% believing that it was only an issue in humans.
Amongst those cat owners who are aware of feline hypertension, only 25% said they would consider asking their vet for a blood pressure check for their pet.
However, once made aware of the risks of high blood pressure, including blindness, seizures and kidney disease, 83% of owners said they would ask their vet for a blood pressure test for their cat.
Dr Natalie Borrill MRCVS, veterinary technical manager for cardionephrology at Ceva Animal Health, said: "Feline hypertension is a common condition in older cats; it is estimated that one in five cats from nine years of age are at risk of suffering from the condition3, but there is a low level of awareness amongst cat owners about this condition.
"By increasing awareness of the disease amongst owners, they will be more inclined to visit the vet with their older cat for regular blood pressure checks. It can also be very helpful for an owner to be present when blood pressure is measured because this can help reduce stress and anxiety in their cat. For more information cat owners can visit amadeus.vet."
The research results were released as part of Feline Hypertension Month, which is running until the end of May to raise awareness of hypertension and improve the detection and management of high blood pressure in cats. As part of the campaign, veterinary practices are being urged to measure their feline patients' blood pressure in cats over the age of seven.
Ceva says it will continue its Mercury Challenge throughout 2019 to increase veterinary professionals' confidence in measuring blood pressure and identifying feline hypertension. Participating practices are given the opportunity to win diagnostic tools to help them identify feline hypertension.
For information, contact cevauk@ceva.com or visit mercurychallenge.ceva.com.
References
The researchers say that research thus far has focused on developing treatments to manage idiopathic epilepsy and little attention has been given to the emotional and logistical challenges for owners managing their dog’s condition.
This study used semi-structured interviews to explore how owners’ lives were changed following their dogs’ diagnosis and glean in-depth insights into their lives.
The research discovered that following their dog’s initial seizure, all interviewees recalled feeling negative emotions such as being distraught, fearful or uncertain regarding their dog’s future and disease progression. Prior experience with canine epilepsy was rare, and owners were shocked and distressed by the appearance of their dog’s seizures.
Whilst many owners discussed a very emotionally close dog-owner bond, owning a dog with epilepsy had a significant impact on their lifestyle. Impacts affected many aspects of daily routines, and in some cases, owners’ jobs. The unpredictable and sometimes inconvenient timing of seizures negatively impacted owners’ sleep and wellbeing. This unpredictability also made some owners feel that they were living with “a ticking time bomb”.
Other limitations included strict daily medication schedules and difficulty finding assistance in caring for their dog. This, combined with a fear of leaving their dog unsupervised, had social implications in some instances and led to increased use of the Internet and online groups for peer support. Owners also reported that friends, family and colleagues did not always understand the magnitude of commitment required.
Amy Pergande, Small Animal Intern at the RVC and primary author of the study, said: "We are sincerely grateful to the owners who participated in this study for providing us with such detailed and often emotive accounts of their experiences. Many of the participants had willingly altered many aspects of their daily routine for their dogs, both socially and professionally, and sometimes at the expense of their own quality of life."
This research highlights that further consideration of these factors by veterinary professionals and the friends and families of owners of these dogs could improve owner quality of life and facilitate the provision of additional, much needed support.
Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science and research lead in canine epilepsy at the RVC, said: "Epilepsy can be an extremely tough condition for owners to manage, where the love, time and money owners dedicate to their dogs is not necessarily matched by a significant improvement in their condition, with seizures often continuing unabated. Our study has revealed previously unrecognised or under-appreciated impacts that epilepsy introduced to these owners’ lives. Improved awareness and understanding of these challenges by veterinary professionals have the potential to improve communication with clients, to avoid owners feeling that social media is the only place they can go to feel supported and understood”.
These findings increase the understanding of the sometimes negative and often profound emotional effects and lifestyle changes experienced by owners managing a dog with idiopathic epilepsy. With better support and resources, the reported impacts could potentially be minimised to protect owner quality of life.
Zoe Belshaw, independent research collaborator, said: “The welfare of pets and their owners can be closely intertwined. This research exploring how owners’ lives change when their dogs develop epilepsy is another important piece in the jigsaw of understanding both what the veterinary profession can do to best support our clients, but also in starting to appreciate the substantial wider societal impacts of chronic ill health in our nations’ pets”.
The full paper is open access and available at: https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-020-02669-w
Reference
Photo: The Melias Studio
CEVA Animal Health has launched Marbokem, a Marbofloxacin-based antimicrobial for the treatment of respiratory disease in cattle which offers the advantages of a one-shot protocol and a shock-resistant vial.
Marbokem is used for the treatment of respiratory infections caused by sensitive strains of Pasteurella multocida, Mannheimia haemolytica and Histophilus somni. CEVA says Marbofloxacin's efficacy has been proven in terms of re-treatment rate, success, speed of action and MICs in comparison with many frequently used quinolones and macrolides. (1,2,3,4)
According to CEVA, Marbokem's one shot protocol means it's quick and economical to use, while its presentation in an ergonomic CLAS vial makes for light and shock-resistant handling, resulting in fewer breakages and reduced costs. The company says Marbokem is also very competitively priced.
For further product information, please contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
1 Grandemange, E., Fournel, S., Woerhle, F. (2009) Field evaluation of the efficacy of 2 antibiotics in treating bovine respiratory infections. Poster, Journées Nationales des GTV, Nantes, France. 2. Grobbel, M., Lübke-Becker, A., Wieler, L., Froyman R., Friederichs, S., Filios, S. (2007) Comparative quantification of the in-vitro activity of veterinary fluoroquinolones. Veterinary microbiology 124 (73-81). 3. Roy, O., Pillet, F., Heurtin-Vallé, A., Frontczak, N. (2008) Comparative field clinical efficacy of a single intramuscular injection of marbofloxacin in the treatment of bovine respiratory disease. Poster, World Buiatrics Congress, Budapest, Hungary.4. Wu, C. (2004) Determination of minimum inhibitory concentrations of danofloxacin and other commonly used cattle antimicrobial agents against Mycoplasma bovis isolated from cattle with clinical disease. Le médecin vétérinaire du Québec. 34 (1-2).
The company says a combination of unprecedented demand for the product and logistics issues, together with an issue involving the manufacturer of the active ingredient, has resulted in a delay in receiving stock into the UK.
Animalcare says it has a shipment awaiting dispatch to the UK from its European manufacturing plant as soon as licensing is completed by the VMD, Home Office and European counterparts. There is another batch in production, expected into the UK in early March.
Kai Crawshaw, Product Manager at Animalcare, said: "We are working hard with the VMD and Home Office to expedite the import licensing process and also with our manufacturer to ensure we can get as much stock as quickly as possible back into the marketplace. We sincerely apologise to any clinics that are experiencing a shortage but are glad to say that stock is on the way."
At the hearing, Dr Crawford made no admissions to the charges against him which involved allegations of: failing to provide adequate and appropriate care; failing to provide adequate clinical histories to another practice in respect of several animals; failing to treat fellow veterinary professionals and other members of staff from another practice with courtesy and respect; failing to maintain adequate clinical records; failing to have in place Professional Indemnity Insurance or equivalent arrangements; and, failing to respond to reasonable requests from the RCVS.
Dr Crawford’s representative drew the Committee’s attention to the fact that Mr Crawford was 71 years old, had no previous disciplinary findings against him and had now ceased practising, including closing his practice premises and notifying his previous clients of the closure.
His representative confirmed that Mr Crawford was fully aware that if his application was accepted, he would no longer be able to practise as a veterinary surgeon or identify as a veterinary surgeon. The Committee also noted that the RCVS had consulted with the complainants who were satisfied with the case being disposed of in this way.
Dr Martin Whiting, chairing the Committee, and speaking on its behalf, said: “Having weighed the public interest in a hearing with the registrant’s interests, the Committee determined that this is not a case in which the public interest required there to be a full hearing. Protection of the welfare of animals would also not be further served by a full hearing. The Committee decided to accede to the respondent’s application.
"The Committee considered that the adjournment on undertakings served to protect the public interest, confidence in the profession and the welfare of animals.
"The Committee carefully considered the detail of the undertakings. It decided, after due consideration that it would accept the respondent’s undertakings in the terms offered and signed."
The Committee also heard that if Dr Crawford were to apply to re-join the Register at a future point, then the adjourned case would be re-opened and a full, public Disciplinary Committee hearing would be held.
The full documentation for the case can be found at: www.rcvs.org.uk/disciplinary
The toolkit is part of a major study, the ‘Old Age Pets (OAP) research project’, recently funded by BSAVA PetSavers at the University of Liverpool.
The ACT includes an owner checklist for home triage and a leaflet which explains the more common health problems affecting aged dogs.
There's a practice waiting room poster which includes a QR code to give clients access to a digital version of the leaflet.
The leaflet recommends working through the checklist at least every six months and keeping completed versions for comparison, to monitor dogs as they age.
PetSavers says that some clients may benefit from advice and guidance from RVNs or PCAs on how to complete the checklist for the first time.
BSAVA has also curated a collection of articles, podcasts, lectures and book chapters to support veterinary professionals in caring for senior dogs: http://www.bsavalibrary.com/petsaversact.
Professor Carri Westgarth from the University of Liverpool said: “We conducted this research project kindly funded by BSAVA PetSavers in order to help owners and veterinary professionals provide great care for our loved pets as they age.
“Our investigations uncovered common physical and behavioural signs in dogs that owners observe and for which support from the veterinary practice would be beneficial.
"Our simple evidence-based checklist is designed to engage owners and importantly stimulate efficient discussion with their veterinary team.”
Free digital copies of the leaflet and poster can be downloaded here: http://www.bsavalibrary.com/content/cilgrouppetsaversact, where veterinary professionals can also request free printed copies for their practices.
https://www.bsava.com/petsavers/our-impact/citizen-science-project.
The expansion has increased the hospital's footprint by 30%, adding three new operating theatres, six new consult rooms and new feline facilities, including a cat-only waiting room, consult room and treatment area.
Hospital owner, IVC Evidensia said the expansion has been driven in part by the pet ownership boom of the last few years and increased demand for the hospital’s services.
To meet the demand, Vale has expanded its office space, adding desk space for a further 25 vets.
There are also new ultrasound and cardiology rooms, a new dental suite and enlarged prep and recovery areas.
The existing kennel area has doubled in size with the addition of nine new walk-in kennels, a bespoke isolation ward and secure outdoor runs.
Richard Artingstall, clinical director at Vale Referrals, said: “We’ve been working on this expansion for a long time and it’s incredible to see it complete.
"Our new and improved facilities mean we can give even more pets across the Southwest the gold standard treatment that they deserve and support our colleagues from neighbouring vet practices with extensive referral services.
"The feedback from pets and owners so far has been very rewarding to hear.”
The feedback from pets?
Really?
VetSurgeon.org contacted recent patient Dougal McDoggins for comment.
He said: "Woof."
www.valereferrals.co.uk.
Nutraplaque contains Ascophyllum Nodosum seaweed and decaffeinated green tea extract, presented in sprinkle capsules. Nutravet says the seaweed in nutraplaque has been shown to reduce plaque build-up by 35% after 4 weeks.
Nutravet says the new product also helps in the removal and control of tartar, supports healthy teeth and gums, reduces bad breath and is free of artificial preservatives, gluten and sugar
Matthew Shaw, Managing Director at Nutravet said: "We’re really excited to introduce nutraplaque into our market-leading range of veterinary exclusive nutraceuticals. Maintaining pets’ dental health is an important part of looking after a pet and our nutraplaque sprinkle capsules make it easy for pet owners to keep up with oral health in an easy to administer form.
“The unique formulation of nutraplaque works naturally within an animal’s body. The natural ingredients work through the saliva, where they help reduce new plaque from forming and soften existing tartar around the clock."
For further information about nutraplaque, visit www.nutravet.co.uk.
Speakers include Prof. Jo Dukes McEwan, Head of Service, Professor in Small Animal Cardiology (University of Liverpool), Doctor Jennifer Schissler, Veterinary Dermatologist, Best Friends Animal Hospital & Urgent Care Unit (US), and Doctor Pascal Prélaud, Dermatologist, CEO ADVETIA Vet Hospital Center (France).
Participants will also be able to access to an immersive experience, the Vet Symposium Village, which includes the Live Stage, Vet Lab, Clinic Lounge, and Innovation Hub, all offering exclusive videos and lectures.
The event will be translated into Chinese, French, Spanish, Italian, Portuguese, Russian, and German, and a replay of the event will be available until the end of the year.
Dr. Jennifer Welser, Chief Medical Officer, Mars Veterinary Health, said: “It’s more critical than ever for pet professionals from various countries, fields, and perspectives to meet and share their knowledge.
"I look forward to participating in the Vet Symposium and speaking with my peers on topics ranging from mental health to advancements in quality medical care and retaining veterinary talent.”
https://digital-vetsymposium2022.com/
The survey of 2717 horse owners, 56% of which were leisure owners and 35% professionals, found that most horses (62%) were retired between 15-24 years of age, mainly for health reasons.
Mares had a higher risk of retirement than geldings, which the researchers say may be due in part to mares used for breeding not doing much structured exercise.
Just over 1 in 6 horses in the study were affected by low muscle mass according to their owners.
Age, sex, osteoarthritis, laminitis, pituitary pars intermedia dysfunction (PPID), and primary use were identified as risk factors for low muscle mass.
Geldings had a higher risk of low muscle mass than mares, which the researchers say may be a result of low testosterone.
Horses with owner-reported veterinary-diagnosed PPID, osteoarthritis and laminitis had a higher risk of low muscle mass.
Primary use was identified as a risk factor for low muscle mass, with retired horses having a higher risk than horses used for competition or pleasure riding.
Owner-reported low muscle mass was perceived to affect welfare and the ability to work in the majority of senior horses.
Alisa Herbst, who led the study, said: “A prolonged working/active life may not only be desired by owners but is also likely to provide health and welfare benefits to the horse.
"We hope the results of this study may be useful for veterinarians caring for senior and geriatric equines, by helping to achieve this."
“The information may aid in the investigation of diseases affecting senior horses and in establishing senior horse-owner education programs.
"The low muscle mass risk factor list may assist vets in identifying horses at risk of low muscle mass to be selected for close monitoring.
“Vets may also consider inclusion of an objective measurement of muscle atrophy, such as the muscle atrophy scoring system (MASS)***, in annual wellness exams, so that atrophy can be identified and managed as early as possible."
Sarah Nelson, Product Manager at Mars Horsecare added: “This survey has highlighted several interesting retirement trends.
“With a better understanding of when and why senior horses are being retired we hope, eventually, to be better placed to monitor for, prevent (where possible), and treat the underlying conditions early on, to help horses stay active and healthy for longer.”
https://www.seniorhorsehealth.com
The Veterinary Record has published what the British Homeopathy Association is calling the first ever systematic review of randomised controlled trials (RCTs) in veterinary homeopathy.
The review was conducted by Dr Robert Mathie, research development adviser to the association, and Dr Jürgen Clausen from the Carstens Foundation, Germany.
They found 18 placebo-controlled RCTs of veterinary homeopathy, published in the peer-reviewed literature, that were eligible for detailed assessment. Of these, only two were judged to provide reliable evidence. The remainder were unclear or had a high risk of bias.
The two studies which were judged reliable were:
HEKTOEN, L., LARSEN, S., ØDEGAARD, S. A. & LOKEN, T. (2004) Comparison of homeopathy, placebo and antibiotic treatment of clinical mastitis in dairy cows - methodological issues and results from a randomized-clinical trial. Journal of Veterinary Medicine. A, Physiology, pathology, clinical medicine 51, 439-446. In this study, homeopathy was shown to be ineffective.
Dr Mathie said: "Up to now, debates about the efficacy or effectiveness of veterinary homeopathy have been polarised by the absence of any systematic review of the subject. Our work clarifies the nature of the current RCT evidence."
Mr Mark Elliott, immediate past president of the British Association of Homeopathic Veterinary Surgeons, said: "This important study affirms that reliable evidence does exist and that more research should be done, particularly in light of current concerns about antibiotic resistance in production animals."
It seems a remarkable admission, that the entire veterinary homeopathy edifice rests upon one study in piglets. However, if that study did prove the efficacy of homeopathy, it would of course be an order of magnitude more remarkable than today's admission.
So, no pressure then, Camerlink et al!
The entertainer Michael Ball yesterday opened the final phase of Fitzpatrick Referrals' new ultra-hi-tech patient ward, which, according to the practice, will elevate animal care to a whole new level in the UK.
The ward boasts bacterial-resistant wipe-down wall coverings and floor surfaces with underground heating, and air conditioning optimised for high efficiency particulate air to minimise the possibility of infection.
Instead of gates or bars, the kennels have reinforced glass doors which permit a wide field of view for the animals and allow them to feel as much at home as possible. Each kennel has a space for medication and notes, and a "quick reference" daily guide is written on the glass door each morning to ensure continuity of care and ease of visibility for all. Each kennel has a radio and many are equipped with televisions to provide auditory and visual stimulation - creating a home from home experience for patients.
The practice says light is an important part of the "care package" offered in the luxury wards, and numerous windows and night time dimmers provide a diurnal rhythm to help comfort anxious animals and help those with separation anxiety to settle. Webcams are easily connected for remote viewing, and each and every patient is checked hourly by the 24 hour care team of ward assistants, fully qualified veterinary nurses, surgical interns, residents and senior clinicians.
Noel Fitzpatrick said: "I've always felt that people who love animals are generally great people, and they absolutely want to know that when their animal friend is away from home, especially if severely ill, that they are receiving round-the-clock care in the best facility imaginable. This in my head does not involve bars, so I have a "no bars" policy. I want the patient to be super-comfortable and not to feel threatened or "in prison", especially when some of them will have severe physical disability."
Michael Ball said: "I saw the Bionic Vet on television but I never thought I would find myself here. Noel has an extraordinary talent for healing and has built an amazing team who truly do care deeply about each and every one of these patients as if they were their own pets. They really do provide an unparalleled level of care. What Fitzpatrick Referrals has managed to do is truly remarkable. When I look at the level of hands-on care and compassion shown by all of team, I'm overwhelmed. I am hugely honoured to be associated with Fitzpatrick Referrals and what this practice stands for. The work which is happening here is benefitting the veterinary world and the human world - it's incredible."
After cutting the ribbon and declaring the new facility officially open, Michael Ball met with Dr Fitzpatrick for the 'see out consultation' for his dog, Freddie, who has been recovering after a major hip operation at the practice.
The Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA) has updated the Vaccination Guidelines it offers to veterinary surgeons.
The association says its Canine and Feline Vaccination Guidelines aim to provide globally applicable recommendations to help veterinary surgeons vaccinate in a standard and scientifically justified fashion.
The VGG has also updated the vaccination guidelines it offers to pet owners and breeders, as well as the series of fact sheets it has created on key global vaccine-preventable diseases of dogs and cats.
The original guidelines were published in 2007 as the WSAVA's initial response to the need for globally applicable recommendations on vaccination best practice. They were updated in 2010 and, since then, the VGG, which is supported exclusively by MSD Animal Health, has been focusing on issues relating to small companion animal infectious disease and veterinary education in Asia.
The 2015 release of the Canine and Feline Vaccination Guidelines is based on a new evidence-based classification system for vaccinology. It also includes a number of additional FAQs (110 in total). The guidelines for both vets and owners/breeders are available for free download at http://www.wsava.org/educational/vaccination-guidelines-group. Currently available in English, they are being translated into a number of languages.
Professor Michael Day, Chair of the VGG (pictured right), said: "The vaccination guidelines are one of the most frequently downloaded resources on the WSAVA's website and are gradually driving a change in vaccination practice throughout the world - a change which is set to have a major impact on day-to-day small animal practice.
"We are delighted to launch these updated versions both for veterinarians and for pet owners and breeders. We hope they will prove even more helpful and ensure that more small animals are vaccinated in a more scientifically-based, robust and safer fashion.
"We would like to thank MSD Animal Health which has been the sole sponsor of the VGG since its inception. Its support enables us to undertake our valuable work."
The award was due to be presented at the association's annual shindig in March, which was cancelled due to the coronavirus pandemic.
VMA Awards chair, Claire Edmunds, said: “This years’ winners will still get their moment of glory on stage next March at the rescheduled event. We can also announce that the event is likely to include some additional categories to recognise campaigns and initiatives undertaken during the COVID-19 pandemic.”
Carlos Michelsen, managing director of award sponsor, CM Research, added: "Thanks to the continued success of Cytopoint, Zoetis achieved highly commended status. But it was Elanco that came in as award winners, with their novel veterinary pharmaceutical product Galliprant taking the crown. Congratulations to Elanco!"
Rebecca Bryant, Elanco’s marketing manager for Pet Health Therapeutics (pictured right), said “Elanco is delighted to be recognised by the veterinary community with this prestigious award for Galliprant. The UK team is proud to be part of the launch of this innovative, first-in-class product which has already enriched the lives of thousands of pet owners and their dogs living with osteoarthritis. It’s fantastic to hear from vets that managing OA with Galliprant has already made a positive impact on their practices.”
Zoetis product manager, Allison Henry said: “We are very proud to come such close second in this award category as it is a true testament to the lasting innovation Cytopoint has brought to our industry, customers and pets. At Zoetis, we always strive to develop innovative new medicines for the veterinary industry and we are thrilled to see how Cytopoint has done just that.”
The charity says that one of the biggest issues it faces with guinea pigs is multi-animal households where breeding has become out of control.
Dr Jane Tyson, the RSPCA’s rodent expert, said: "We would always advise owners to have their male guinea pigs neutered before introducing them to a female. We also find that they can sometimes be mis-sexed by the seller or previous owner which leads to accidental breeding so it’s also important to make sure that guinea pigs see a vet regularly who would be able to spot if they have been identified incorrectly.
“Many of the guinea pigs that come into our care have come from a multi-animal home where there have been large numbers of guinea pigs living in often cramped, dirty and unsuitable conditions. This also means that they may have experienced very little handling and are wary and fearful of human hands and need their confidence building up in RSPCA care.
“This is why, this Guinea Pig Appreciation Day, we wanted to encourage people to neuter their guinea pigs and help tackle the problem of overbreeding.”
Petplan has launched a new look policy range to give pet owners more comprehensive cover and make it easier for them to understand the types of cover available.
Simon Masding, Petplan's Head of Sales and Partnerships said the refreshed policies will not only benefit the pet and their owner but the changes will also allow veterinary staff to explain the policies with a lot more clarity: "Since Petplan started 35 years ago the pet insurance market and vet industry has changed significantly, especially in the last few years. There are now over 250 policies in the market with varying benefits and levels of cover, which often confuses customers to a point where they think they're getting lifetime cover but they're instead trapped with a restrictive policy.
"The veterinary industry is also continually changing with advances in new technology and better diagnostics allowing the industry to save and treat more pets, which means our policies need to evolve with them."
To better understand these changing market dynamics, Petplan held focus groups with veterinary staff from across the UK and undertook extensive research with charities, breeders, customers and non-customers.
Apparently, the feedback showed that Petplan needed to communicate its range of policies more clearly, to shift away from the confusion created by other brands and meet the changing demands of the vet industry and pet owners better.
For this reason, Petplan says it has simplified its policy range, adding and increasing each policy's benefits, making a 12 month policy available for practices to offer, and developing easy-to-understand policy names.
Petplan's new look policies for both cats and dogs are:
Petplan says its Covered for Life policies, Petplan Ultimate and Petplan Classic, will continue to provide pet owners with the best cover in the market. However, the company recognises that these policies are not always suitable for people with older pets or a limited budget.
Simon said: "Petplan Essential, our 12 month policy, will also now be available for veterinary staff to offer to their customers. While our Covered for Life Ultimate and Classic will continue to be our leading policies and at the heart of what we do, it's better that a pet owner has some type of cover rather than nothing at all and Essential is a market leading 12 month policy."
Zeta Frasca, practice owner and vet at Kitten to Cat in Richmond London said: "These changes will not only make it clearer for the pet owner but it will also make it a lot easier for us as an industry to explain pet insurance to our clients, which is really important."
For more information about Petplan's new look policies visit www.petplan.co.uk, call their dedicated Vetline on 0800 3168 8900 or talk to your Petplan Business Developer.
The following table outlines each policy and its benefits:
The scheme, which is part of the company's Keeping Britain’s Horses Healthy campaign, includes a pack - endorsed by BEVA and World Horse Welfare - to help yard owners and vets educate owners why they should vaccinate and the benefits of preventative healthcare.
The Yard Excellence Scheme pack includes information on vaccination, weight management, worming and biosecurity. It also helps yard owners implement a range of preventative protocols covering things like worming, vaccination and managing new arrivals, and also put infectious disease outbreak protocols in place.
There are also various things to promote the scheme within the yard, such as yard posters, a horse owner checklist, horse records and responsible horse owner booklets.
All the yards that develop and implement appropriate protocols, in collaboration with their vet, will achieve the Keeping Britain’s Horses Healthy Yard Excellence Scheme Standard and will be promoted on the scheme's Facebook page (@keepinghorseshealthy).
Yards can also promote their achievement via social media and on their website.
Fieke Bennett, equine business manager at MSD Animal Health said: "Our KBHH Yard Excellence Scheme is aimed at encouraging yards and vets to collaborate more closely towards excellent preventative healthcare practices.
"By encouraging vaccination and other preventative healthcare practices, livery yards will have a healthier population of horses; achieving an environment with happy horses, happy owners, and excellent yard reputation.
"This collaboration supports a strong relationship between the vet and the yard, a healthy yard means owners can enjoy their love of horses without restriction."
For further information talk to your MSD Animal Health Equine Account Manager, ring 01908 685685 or refer to KBHH social media feeds on Facebook page and Twitter (@keepinghorseshealthy).
Matthew’s award is in recognition of his paper Approach to initial management of canine generalised epileptic seizures in primary-care veterinary practices in the United Kingdom, co-authored with Laurent Garosi, which was selected by the BSAVA Committee as being the most valuable to veterinary practice.
James’ study explored data collected as part of the Small Animal Veterinary Surveillance Network (SAVSNET) at the University of Liverpool.
In total, clinical records concerning 3,150,713 consultations (917,373 dogs) were collected and analysed from 224 UK veterinary practices.
This included the management of canine generalised epileptic seizures in 517 dogs up to 6 years of age.
The study concluded that 98% of dogs presenting for a single epileptic seizure were not started on long-term therapy, in accordance with the approach recommended by the International Veterinary Epilepsy Task Force (IVETF).
Other findings from the study included:
The paper also reported on factors potentially associated with prescription of ASDs.
It stated that dogs who presented for cluster seizures (more than one epileptic seizure in a 24-hour period) were more likely to be prescribed ASDs, or to be referred to a specialist, than dogs without cluster seizures.
Dogs that were neutered or microchipped were more likely to be started on ASDs following the initial presentation, perhaps suggesting that owners who take part in regular preventative healthcare prior to the onset of their dog’s seizures could be more willing to start therapy in the earlier stages of the disease.
In addition, more than half of dogs with cluster seizures were not prescribed any ASDs.
Given that the presence of cluster seizures is typically considered an indication to start long-term therapy by the IVETF, Matthew says this may be one aspect of seizure management that could be improved in primary care practice.
Regarding the choice of anti-seizure drugs (ASDs), imepitoin was more frequently prescribed than phenobarbital in response to cluster seizures.
But unlike phenobarbital, the paper highlighted that the market authorisation for imepitoin does not include the treatment of cluster seizures.
Therefore vets should be aware that the use of imepitoin for cluster seizures should be considered as “off-licence” - and has additional implications for obtaining informed consent.
Matthew said: “We believe this research contributes to an improved understanding of the current management strategies for canine epilepsy in general practice and how this compares to the current guidelines advised by the IVETF.
"Given the prevalence of epileptic seizures within the UK canine population, as well as the large proportion of dogs that will be managed entirely within general practice without referral to a neurologist, it is vital to ensure that the level of care being provided is optimal.
"We therefore hope that this research ultimately supports and guides general practitioners in their approach to canine epilepsy, thereby improving the quality of life of affected dogs and their owners.”
https://onlinelibrary.wiley.com/doi/epdf/10.1111/jsap.13543
Stewart Halperin (pictured right), the vet who founded CarefreeCredit, said: "We originally started out by helping vets provide loans to treat pets needing medical attention which wasn’t covered by insurance, allowing them to provide the care needed, while also being paid immediately, improving cash flow and reducing bad debts.
"With this new service, vets can make their services better known in their local communities, which will also boost their turnover and allow them to care for even more animals."
Practices that use CarefreeCredit are given access to an online application process that takes around five minutes, providing loans from £250 upwards for use against any veterinary bills.
A range of credit terms are available from 0% APR upwards. They are also the only company to offer loan rates based on risk, which they say means more clients are likely to be accepted for finance.
CarefreeCredit practices that want to use the PR service need to contact the company, whereupon they'll arrange for an award-winning public relations consultant to provide the support they need - free of charge.
For further information, visit: www.carefreecredit.co.uk or call 0345 313 0177.
Vetnapp offers a secure alternative to traditional paper records, allowing for the entry of drugs administered, recording of physiological parameters (for example, heart rate, respiratory rate, blood pressure), and recording complications occurring during an anaesthetic.
The final anaesthetic chart can be converted to a PDF and attached to patient records, simplifying the paper trail.
Alastair, who works at Willows Referrals, says his motivation for developing the app was born out of frustration with handwritten anaesthetic records which can often be incomplete, illegible and easily lost.
Alastair said: "Vetnapp is excellent for ease of data entry via the use of sliders and drop-down lists. It also stores records, allowing easy retrieval, which is not possible with paper records.
"Now the app is available for both Apple and Android devices, it is much more accessible. I have even had people downloading it in Australia, America and China, which is fantastic."
"It’s still very much early days and I hope its popularity grows over time. Ideally, I would like it to be downloaded by veterinary groups, as well as independent practices."
To download Vetnapp, visit the App Store or Google Play and search 'Vetnapp'.
The device emits low dose 265 nanometre (nm) ultraviolet C light at a targeted area.
In a 2022 in vitro / ex vivo study to evaluate the therapeutic potential of 265nm UVC for infectious keratitis1, UVC was found to inhibit all tested bacteria and fungi, including mixed culture and strains linked to antibiotic resistance.
In the study, no evidence of infection was found from 4 hours onwards, ulcers responded significantly in under 24 hours, and at the end point, those treated with UVC performed as as well as those treated with ciprofloxacin.
Photon Therapeutics says that in simple cases, one five-second treatment will suffice, but more complex cases can be re-treated after 24 hours.
Currently, there are two main barriers to the successful treatment of eye infections in dogs.
The first is the difficulty diagnosing the infection and identifying the right antimicrobial to use, highlighted by a 2017 study: Bacterial Isolates from Canine External Ocular Disease and their Antimicrobial Sensitivities 2.
The second is whether the owner is able or willing to administer a topical treatment.
Here the evidence suggests that even when treatment is possible, people do not comply with clinical advice anything like as much as they claim.
Photon Therapeutics points to what it says is the nearest study there is, in which carers of young children with uveitis did not give the correct treatment in 75% of cases3.
If the device is as effective as claimed, then both these issues simply evaporate.
PhotonUVC costs £4,995.
https://photon-therapeutics.com
VetSurgeon.org product briefing: https://www.vetsurgeon.org/m/veterinary-product-briefing/138134
Plimsoll has published the results of a study into the profitability of UK veterinary practices which has revealed a widening gap between firms making outstanding profits and those losing money.
The Plimsoll Analysis found average profit margins have fallen to 6.4% of sales and 151 of the UK's top 500 practices are now running at a loss. However, the same study has revealed 61 businesses are making record profits.
Of the 61 'rich' companies:
Of the 151 'poor' companies:
David Pattison, senior analyst at Plimsoll, said: "Sometimes the public perception of profit is wrong. It's seen as companies taking advantage of their position or exploiting their commercial advantages unfairly. But these successful companies should be proud of their achievements. In an industry not known for its successes, these businesses should act as benchmarks to the rest of the industry showing what can be achieved."
Mr. Pattison added: "The latest Plimsoll Analysis highlights that the industry is being split into two types of company and the gap between the rich and the poor is getting bigger and bigger.
"For the companies that are falling behind, they need to re-evaluate their strategy and retain profit in order to improve their financial strength."
The Plimsoll Analysis provides an individual profile of each of the UK's top practices. It offers an overall financial rating, a valuation and an acquisition attractiveness assessment on each company. VetSurgeon.org members can have a £50 discount off this report by calling 01642 626419 and quoting reference PR/AA54.
For more information, contact Chris Glancey on 01642 626 419, or email c.glancey@plimsoll.co.uk
The company, which was founded by scientists from the human field, managed to raise £8 million of Series A funding by February this year. It is now seeking further investment for an extension to that Series A funding by the autumn.
The company's Chief Scientific Officer is Professor Allan Bradley, Emeritus Director of the Wellcome Trust Sanger Institute and a Fellow of the Royal Society (pictured right). He spearheaded the development of mouse transgenics and their translational use, which provided the basis for developing canine monoclonal antibody therapies.
Allan said: "We are growing a world-class scientific team that will enable PetMedix to become a global leader in the development of novel monoclonal antibody therapies for the expanding animal health market. In the short lifetime of the company we have attracted huge talent in both our scientists and executives, and moved into the heart of the Cambridge biotech sphere with its excellent facilities and networking opportunities. The recent appointment of Dr. Fabian Kausche to the board marks our intent to become a global leader in animal health."
CEO, Dr. Tom Weaver added: "We have the people and the technology in place, and are champing at the bit to progress these therapies to reach the pets that could benefit. We know this technology has transformed the treatment and survival of human patients with a variety of conditions and we want to create the same paradigm shift in veterinary treatment options to improve welfare, quality of life and longevity for our dogs and cats."
PetMedix says it is interested in hearing from potential investment partners, and mergers and acquisitions. Contact Jolyon Martin via email: jolyon.martin@PetMedix.co.uk or telephone: +44 (0) 1223 734140,